NCT02516904View on ClinicalTrials.gov

A Single Ascending Dose Study of CD101 IV in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

CD101 IV

antifungal

DRUG

Placebo

normal saline

Trial Locations (1)

85283

Celerion Inc, Tempe

Sponsors
All Listed Sponsors
lead

Cidara Therapeutics Inc.

INDUSTRY